Alizé Pharma 3, a company specialized in developing therapeutic peptides for rare endocrine and metabolic diseases, today announces that it has completed a €67 million Series A financing round. The oversubscribed Series A was led by LSP, and included Novo Ventures,...
After a first round of $350k in January 2016, the French startup MailClark just announced that it has raised $900k in a second round led by Kreaxi, with participation from existing investor IT Translation as well as private and public funds. Founded in December 2014,...
– Definitive purchase agreement whereby Boston Scientific will acquire Symetis for $435 million in an all cash, up-front payment – Acquisition of Symetis will expand the treatment offerings for patients with aortic valvular heart disease –...
Recent Comments